Argus Biosciences LLC Company Profile

13:33 EST 22nd November 2017 | BioPortfolio

Argus Biosciences was founded in 2003 by Dr. David Whyte.Dr. Whyte received his Ph.D. in Molecular Biology from the University of California, San Francisco, and has a Bachelors of Science degree in Chemistry from the University of Michigan, Ann Arbor.After receiving his doctorate, Dr. Whyte worked as a Principal Scientist at the Schering Plough Research Institute in Kenilworth, New Jersey, and as Director of Molecular Technologies at SUGEN, South San Francisco, California.
Our focus is personalized DNA sequence analysis.In addition to offering sequence analysis of medically significant genes, we have recently added a suite of products in the area of molecular genealogy.


2033 Ralston Ave, #84
United States of America


Phone: 650-954-1055

News Articles [609 Associated News Articles listed on BioPortfolio]

4C Pharma Solutions launches E2B(R3) compliant systems

4C Pharma Solutions launched prevalidated Oracle Argus Safety 8.1 and Backwards Forwards Compatibility (BFC) tool to convert E2B (R3) XML files to R2 format. Argus Safety is a complete pharmacovigilan...

Second Sight Announces Market Entry into Russia with First Implant of Argus II Retinal ...

- Marks Continued Global Expansion of Argus II for Individuals Blinded by Retinitis Pigmentosa - Read more...

Second Sight Announces Expansion of Medicare Coverage for Argus II Retinal Prosthesis System to ...

-- Argus II Can Now Be Covered in Seven of 12 Medicare Administrative Contractor Jurisdictions, representing a total of 28 states, two territories, and the District of Columbia -- R...

CMS expands reimbursement coverage for Second Sight's Argus II system

The CMS has given expanded reimbursement coverage for Second Sight Medical's Argus II retinal prosthesis system, authorizing  -More- 

positives Votum für Gilead Sciences-Aktie ist Geschichte! - Aktienanalyse

New York - Gilead Sciences-Aktienanalyse des Analysten David Toung von Argus Reseaerch: Aktienanalyst David Toung vom Investmenthaus Argus Research empfiehlt die Aktien des US-Biotechkonzerns Gilea...

Comprehensive Review of Health Claims Results in $4.3 Million Saved for TPA Clients

Appleton, WI (PRWEB) October 10, 2017 A third party administrator (TPA) based in the Midwest, Cypress Benefit Administrators has a...

Mylan's Stock Is No Longer A Buy According To Analysts At Argus

Analysts at Argus no longer hold a bullish view on Mylan N.V. after the company cut its full-year guidance and cautioned that its earnings per share will decline in 2017. The firm's Jasper Hellweg...

Harmony Biosciences gains US rights to pitolisant; raises $270 million

USA-based Harmony Biosciences, a part of the Paragon Biosciences corporate family, has acquired the exclusive…

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Naturally nova scotia hand sanitizer [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Natelle one [Azur Pharma, Inc.]

Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron

Natelle one [Azur Pharma, Inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

PubMed Articles [75 Associated PubMed Articles listed on BioPortfolio]

Comparative toxic responses of male and female lizards (Eremias argus) exposed to (S)-metolachlor-contaminated soil.

Soil contamination caused by the widespread use of pesticides is one of the main environmental problems facing conservation organizations. (S)-metolachlor (SM) is a selective pre-emergent herbicide th...

A new species of Carcinonemertes, Carcinonemertes conanobrieni sp. nov. (Nemertea: Carcinonemertidae), an egg predator of the Caribbean spiny lobster, Panulirus argus.

A new species of nemertean worm belonging to the genus Carcinonemertes is described from egg masses of the Caribbean spiny lobster Panulirus argus from the Florida Keys, Florida, USA. This is the firs...

Draft Genome Sequences of Trichophyton rubrum CMCC(F)T1i and Trichophyton violaceum CMCC(F)T3l by Illumina 2000 and Pacific Biosciences.

One strain of Trichophyton rubrum CMCC(F)T1i (=CBS 139224) isolated from onychomycosis and one strain of Trichophyton violaceum CMCC(F)T3l (=CBS 141829) isolated from tinea capitis in China were whole...

Amnesia and criminal responsibility.

Back cover.

Clinical Trials [11 Associated Clinical Trials listed on BioPortfolio]

New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis System

This post-approval study is being implemented to monitor the use of Argus II System in a larger US population than available within pre-approval studies. An attempt will be made to includ...

Argus™ II Retinal Stimulation System Feasibility Protocol

The objective of this feasibility study is to evaluate the safety and utility of the Argus II Retinal Stimulation System in providing visual function to blind subjects with severe to profo...

Argus II/ORCAM Device Study

This study is being done to determine if wearable text-to-speech (TTS) and visual pattern recognition (VPR) technology can be used to extend the capabilities of the Argus II to allow patie...

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Study of Low-level Laser Therapy in the Acute Treatment of Migraine

This study evaluates the treatment of migraine pain using low energy laser light to quench migraine signals issuing from the sphenopalatine ganglion (SPG).

Companies [358 Associated Companies listed on BioPortfolio]

Argus Biosciences LLC

Argus Biosciences was founded in 2003 by Dr. David Whyte.Dr. Whyte received his Ph.D. in Molecular Biology from the University of California, San Francisco, and has a Bachelors of Science degree in Ch...

Argus Dental Plan

Founded in 2007 by a Florida dentist, Argus Dental Plan provides dental benefits that offer value and quality to all members. Argus is licensed through the Florida Department of I...

Argus Health Systems, Inc.

Argus is the leading independent provider of health care information management services supporting commercial, Medicare Part D, and Medicaid through a fully transparent business model. Argus is a who...

Argus Media

Argus is a leading provider of price assessments, business intelligence and market data on the global crude and products, natural gas, coal, electricity, emissions and transportation industries. It is...

Argus Dental & Vision, Inc.

Founded in 2007 by a Florida dentist, Argus Dental & Vision provides dental and vision benefits that offer value and quality to members. Argus is licensed through the Florida Depa...

More Information about "Argus Biosciences LLC" on BioPortfolio

We have published hundreds of Argus Biosciences LLC news stories on BioPortfolio along with dozens of Argus Biosciences LLC Clinical Trials and PubMed Articles about Argus Biosciences LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Argus Biosciences LLC Companies in our database. You can also find out about relevant Argus Biosciences LLC Drugs and Medications on this site too.

Quick Search

Relevant Topic

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Corporate Database Quicklinks

Searches Linking to this Company Record